460 related articles for article (PubMed ID: 19527389)
1. Is the surgical approach beneficial to subfertile women with symptomatic extensive adenomyosis?
Wang PH; Fuh JL; Chao HT; Liu WM; Cheng MH; Chao KC
J Obstet Gynaecol Res; 2009 Jun; 35(3):495-502. PubMed ID: 19527389
[TBL] [Abstract][Full Text] [Related]
2. Fertility outcome of infertile women with adenomyosis treated with the combination of a conservative microsurgical technique and GnRH agonist: long-term follow-up in a series of nine patients.
Huang BS; Seow KM; Tsui KH; Huang CY; Lu YF; Wang PH
Taiwan J Obstet Gynecol; 2012 Jun; 51(2):212-6. PubMed ID: 22795096
[TBL] [Abstract][Full Text] [Related]
3. Clinical application and midterm results of laparoscopic partial resection of symptomatic adenomyosis combined with uterine artery occlusion.
Kang L; Gong J; Cheng Z; Dai H; Liping H
J Minim Invasive Gynecol; 2009; 16(2):169-73. PubMed ID: 19249704
[TBL] [Abstract][Full Text] [Related]
4. Prospective randomized study comparing the GnRH-agonist leuprorelin acetate and the gestagen lynestrenol in the treatment of severe endometriosis.
Regidor PA; Regidor M; Schmidt M; Ruwe B; Lübben G; Förtig P; Kienle E; Schindler AE
Gynecol Endocrinol; 2001 Jun; 15(3):202-9. PubMed ID: 11447732
[TBL] [Abstract][Full Text] [Related]
5. [Outcome analysis of stage III - IV endometriosis after conservative surgery].
Li Y; Zhu HL; Liang XD; Zhang C; Wang ZH; Cui H
Zhonghua Fu Chan Ke Za Zhi; 2007 Feb; 42(2):92-5. PubMed ID: 17442181
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of gonadotropin-releasing hormone agonist and an extended-interval dosing regimen in the treatment of patients with adenomyosis and endometriosis.
Kang JL; Wang XX; Nie ML; Huang XH
Gynecol Obstet Invest; 2010; 69(2):73-7. PubMed ID: 19923847
[TBL] [Abstract][Full Text] [Related]
7. The influence of adenomyosis in patients laparoscopically treated for deep endometriosis.
Landi S; Mereu L; Pontrelli G; Stepniewska A; Romano L; Tateo S; Dorizzi C; Minelli L
J Minim Invasive Gynecol; 2008; 15(5):566-70. PubMed ID: 18722969
[TBL] [Abstract][Full Text] [Related]
8. Use of a gonadotropin-releasing hormone agonist to manage perimenopausal women with symptomatic uterine myomas.
Wang PH; Lee WL; Cheng MH; Yen MS; Chao KC; Chao HT
Taiwan J Obstet Gynecol; 2009 Jun; 48(2):133-7. PubMed ID: 19574174
[TBL] [Abstract][Full Text] [Related]
9. [Conservative surgery combined with depot medroxyprogesterone acetate in treatment of moderate or severe endometriosis].
Zhou J; Lei ZW; Lü JQ; Sun J; Xu XW
Zhonghua Fu Chan Ke Za Zhi; 2005 Jan; 40(1):5-8. PubMed ID: 15774083
[TBL] [Abstract][Full Text] [Related]
10. Conservative surgical management for diffuse uterine adenomyosis.
Nishida M; Takano K; Arai Y; Ozone H; Ichikawa R
Fertil Steril; 2010 Jul; 94(2):715-9. PubMed ID: 19406396
[TBL] [Abstract][Full Text] [Related]
11. [Levonorgestrel-releasing intrauterine system for treatment of dysmenorrhea associated with adenomyosis].
Sheng J; Lu D; Zhang JP; Cui GF
Zhonghua Fu Chan Ke Za Zhi; 2006 Jul; 41(7):467-70. PubMed ID: 17083813
[TBL] [Abstract][Full Text] [Related]
12. Hormonal suppression treatment or dietary therapy versus placebo in the control of painful symptoms after conservative surgery for endometriosis stage III-IV. A randomized comparative trial.
Sesti F; Pietropolli A; Capozzolo T; Broccoli P; Pierangeli S; Bollea MR; Piccione E
Fertil Steril; 2007 Dec; 88(6):1541-7. PubMed ID: 17434511
[TBL] [Abstract][Full Text] [Related]
13. [Clinical observation of conservative surgery for adenomyosis].
Liu X; Huang H; Huang R; Lian L; Lang J
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1998 Dec; 20(6):440-4. PubMed ID: 11717936
[TBL] [Abstract][Full Text] [Related]
14. Gonadotropin-releasing hormone agonists and laparoscopy in the treatment of adenomyosis with infertility.
Lin J; Sun C; Zheng H
Chin Med J (Engl); 2000 May; 113(5):442-5. PubMed ID: 11776101
[TBL] [Abstract][Full Text] [Related]
15. Reproductive performance of severely symptomatic women with uterine adenomyoma who wanted preservation of the uterus and underwent combined surgical-medical treatment.
Chang WH; Wang KC; Lee NR; Huang N; Su WH; Chao HT; Yen MS; Fuh JL; Wang PH
Taiwan J Obstet Gynecol; 2013 Mar; 52(1):39-45. PubMed ID: 23548216
[TBL] [Abstract][Full Text] [Related]
16. A randomized study comparing triptorelin or expectant management following conservative laparoscopic surgery for symptomatic stage III-IV endometriosis.
Loverro G; Carriero C; Rossi AC; Putignano G; Nicolardi V; Selvaggi L
Eur J Obstet Gynecol Reprod Biol; 2008 Feb; 136(2):194-8. PubMed ID: 17178185
[TBL] [Abstract][Full Text] [Related]
17. Concomitant treatment of severe uterine adenomyosis in a premenopausal woman with an aromatase inhibitor and a gonadotropin-releasing hormone agonist.
Kimura F; Takahashi K; Takebayashi K; Fujiwara M; Kita N; Noda Y; Harada N
Fertil Steril; 2007 Jun; 87(6):1468.e9-12. PubMed ID: 17222833
[TBL] [Abstract][Full Text] [Related]
18. Infertile women with deep and intraperitoneal endometriosis: comparison of fertility outcome according to the extent of surgery.
Douay-Hauser N; Yazbeck C; Walker F; Luton D; Madelenat P; Koskas M
J Minim Invasive Gynecol; 2011; 18(5):622-8. PubMed ID: 21802376
[TBL] [Abstract][Full Text] [Related]
19. Uterine adenomyosis in persistence of dysmenorrhea after surgical excision of pelvic endometriosis and colorectal resection.
Ferrero S; Camerini G; Menada MV; Biscaldi E; Ragni N; Remorgida V
J Reprod Med; 2009 Jun; 54(6):366-72. PubMed ID: 19639926
[TBL] [Abstract][Full Text] [Related]
20. Changes in tissue inflammation, angiogenesis and apoptosis in endometriosis, adenomyosis and uterine myoma after GnRH agonist therapy.
Khan KN; Kitajima M; Hiraki K; Fujishita A; Sekine I; Ishimaru T; Masuzaki H
Hum Reprod; 2010 Mar; 25(3):642-53. PubMed ID: 20008888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
